Mariam S. Darsot, President

Mariam S. Darsot, a chemist by training, is the chairman and chief executive officer of Nexus Pharmaceuticals. Ms. Darsot formed Nexus Pharmaceuticals in 2003 and has been Chairman and CEO since inception. In her role Ms. Darsot is responsible for directing the company's global strategy, business development and key growth initiatives.

Before starting Nexus Pharmaceuticals, Ms. Darsot was a manager at GeoAnalytical Laboratories in Cleveland, Ohio. Prior to that, she worked for GTEL Laboratories, Westech Laboratories and Triangle Laboratories in various analytical chemist roles.

Ms. Darsot holds a Masters in Organic Chemistry from Miami University, in Oxford, Ohio.

Shahid Ahmed, Chief Scientific Officer

Shahid Ahmed joined Nexus Pharmaceuticals in 2007. A chemist by training, Mr. Ahmed has spent his career helping pharmaceutical companies develop new and generic products and spearhead them through the FDA approval process.

Before joining Nexus Pharmaceuticals, he served as vice president of regulatory affairs at American Pharmaceutical Partners, a division of Fresinius Kabi, where he was responsible for obtaining FDA approval of over 40 Abbreviated New Drug Applications (ANDAs). He also held a series of positions at Ben Venue Laboratories, a Division of Boehringer Ingelheim, including vice president of regulatory affairs, quality control and microbiology, where he was responsible for obtaining FDA approval of 51 ANDAs and one NDA. Prior to that, he served in technical, scientific and management roles in research and development with Sanofi Winthrop Pharmaceuticals, Steris Laboratories, Glaxo and Warner Lambert.

Mr. Ahmed holds a Masters in Analytical Chemistry from Manitoba University

A commitment to providing safe, affordable generic medicines.